Skip to content

Tox Volume

The tox compartment represents the tissue where on-target toxicity is being modeled. Tox Volume, \(V_{tox}\) is set to the volume within the tissue of interest that can be occupied by the drug. Most antibody-based or protein-based biotherapeutics are restricted to the extracellular space, so Tox Volume is set to represent the tissue interstitial volume.

Typical Values

The interstitial volume of tissues have been reported in literature and summarized as parameters in physiologically based pharmacokinetic (PBPK) models.

For example, Shah and Betts 2012 report values for interstitial volume of tissues:

Tissue Human (mL) Mouse (mL) Rat (mL) Rhesus Monkey (mL)
Heart 48.8 0.0217 0.146 4.05
Lung 300 0.0384 0.263 10.7
Muscle 3910 1.47 15.8 426
Skin 1125 1.66 16.5 223
Adipose 2289 0.337 5.63 26.3
Bone 1891 0.525 3.90 177
Brain 261 0.0873 0.410 16.9
Kidney 49.8 0.0788 0.361 4.09
Liver 429 0.385 2.56 37.4
Small Intestine 67.1 0.127 0.867 17.2
Large Intestine 95.3 0.0545 0.500 24.4
Pancreas 18 0.0169 0.173 2.17
Thymus 1.09 0.00153 0.0163 0.355
Spleen 44.3 0.0254 0.554 1.19
Other 831 0.0797 1.04 22.7

References

  • Shah, Dhaval K., and Alison M. Betts. 2012. "Towards a Platform PBPK Model to Characterize the Plasma and Tissue Disposition of Monoclonal Antibodies in Preclinical Species and Human." Journal of Pharmacokinetics and Pharmacodynamics 39 (1): 67–86. https://pubmed.ncbi.nlm.nih.gov/22143261/